Clinical Trials Directory

Trials / Completed

CompletedNCT01566760

A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers

Open-Label, Single-Dose, Randomized, Crossover Study To Estimate The Effects Of Food On The Pharmacokinetics Of Two Fesoterodine Sustained-Release Beads-In-Capsule Formulations And To Estimate The Relative Bioavailability Of One Or Both Formulations Compared To Commercial Tablet Formulation In Healthy Adult Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 2-cohort, 3-period study to characterize the pharmacokinetics (process by which drug fesoterodine is absorbed, distributed, metabolized, and eliminated by the body) and the effects of food on the pharmacokinetics of the drug. This study will take place over approximately 8 weeks and will consist of a screening visit to determine eligibility for the study, and 2- or 3-period treatment phase for each cohort.

Conditions

Interventions

TypeNameDescription
DRUGfesoterodine fumarateOne capsule of 4 mg PF-00695838 Formulation SR1 under fasting conditions, single dose
DRUGfesoterodine fumarateOne capsule of 4 mg PF-00695838 Formulation SR2 under fasting conditions, single dose
DRUGfesoterodine fumarateOne capsule of 4 mg PF-00695838 Formulation SR1 under fed conditions, single dose
DRUGfesoterodine fumarateOne capsule of 4 mg PF-00695838 Formulation SR2 under fed conditions, single dose
DRUGfesoterodine fumarateone extended-release tablet of commercially available fesoterodine fumarate 4 mg under fasting conditions, single dose

Timeline

Start date
2012-05-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2012-03-29
Last updated
2016-08-19

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT01566760. Inclusion in this directory is not an endorsement.